Technology Evolution on Prothrombin Complex Concentrate (PCC) Market

According to the Fortune Business Insights report, titled "Prothrombin Complex Concentrate (PCC) Market Size, Share and Industry Analysis By Product Type (3-factor PCC, 4-factor PCC), By Application (Congenital and Acquired Coagulation Factor deficiency), By End User (Hospitals, Ambulatory Surgical Centers), and Regional Forecast 2018-2025", the market value stood at USD 536.3 million in 2017. The report also contains a bird's eye-view analysis of the overall industry outlook and a worm's eye-view assessment of the various factors, future prospects, upcoming trends, regional dynamics, and competitive landscape that will shape the market in the forecast period.

Highlights of the Report:

o In-depth analysis of various insights, namely, Prothrombin Complex Concentrate Market trends, growth drivers, opportunities, and other related challenges.
o Comprehensive details of key market players, their core competencies, and Prothrombin Complex Concentrate Market share.
o The potency of suppliers and buyers to make better business decisions.
o Lists out the market size in terms of volume.

For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/industry-reports/prothrombin-complex-concentrate-pcc-market-100102

Key Players Operating in The Prothrombin Complex Concentrate Market Include:

Key players are involved in mergers and acquisition to strengthen their market position. Owing to increasing competition frequent innovations are taking place in the market. Some of the companies operating the industry are:

o Sanquin
o China Biologic Products Holdings, Inc.
o Grifols SA
o Shire
o Octapharma AG
o Kedrion S.p.A
o CSL Behring

Growing Utilization of 4-Factor PCC to Boost Sales
The 4-factor prothrombin complex concentrate (4F-PCC) is used to expedite the reversal of vitamin K antagonist (VKA). It carries several benefits which is fuelling its popularity. For example, this PCC variant contains coagulation factor VII, which is not present in other variants. Furthermore, administering 4F-PCC is relatively easy as it requires a reduced infusion volume and it also minimizes the risk of pathogen transmission. Effectivity of its treatment mechanism has surged its adoption rate and given it international recognition. For instance, the British Committee for Standards in Haematology has prescribed specific guidelines for the deployment of PCC techniques in treating haemophiliacs. These developments are expected to provide a positive thrust to the market for this medication technology.

Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/prothrombin-complex-concentrate-pcc-market-100102

Asia-Pacific to Boast a High CAGR; North America to Dominate

With a revenue generation of USD 210.2 million in 2017, North America is set to lead the global prothrombin complex concentrates market share in the forecast period. This is mainly owing to the presence of major players in the region. Evolving health insurance policies for rare blood disorders and increase in the number of plasma collection centres in India and China will enable Asia-Pacific to grow at an impressive CAGR till 2025. In Europe, the market will be driven by the rising prevalence of congenital coagulation factors deficiency.

Detailed Table of Content:

o Introduction
o Research Scope
o Market Segmentation
o Research Methodology
o Definitions and Assumptions
o Executive Summary
o Market Dynamics
o Market Drivers
o Market Restraints
o Market Opportunities
o Key Insights
o Prevalence of Coagulation Factor Deficiency - For Key Countries
o Recent Industry Developments - Partnerships, Mergers & Acquisitions
o Regulatory Scenario - For Key Countries
o Analysis in Relation to Alternatives to PCC
o Global PCC Market: Reimbursement Scenario & Key Industry Trends
o Global Prothrombin Complex Concentrate Market Analysis, Insights and Forecast, 2014-2025
o Key Findings / Summary
o Market Analysis, Insights and Forecast - By Product
? 3-factor PCC
? 4-factor PCC
o Market Analysis, Insights and Forecast - By Application
? Acquired coagulation factor deficiency
? Congenital coagulation factor deficiency
o Market Analysis, Insights and Forecast - By End User
? Hospitals
? Ambulatory Surgical Centers
? Others
o Market Analysis, Insights and Forecast - By Geography
? North America
? Europe
? Asia Pacific
? Latin America
? Middle East & Africa
o North America Prothrombin Complex Concentrate Market Analysis, Insights and Forecast, 2014-2025

Have Any Query? Ask Our Experts: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/prothrombin-complex-concentrate-pcc-market-100102

About Us:

Fortune Business Insights(TM) offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

At Fortune Business Insights(TM) we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.

Contact Us:
Fortune Business Insights(TM) Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune - 411045, Maharashtra, India.

Phone:
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245
Email: sales@fortunebusinessinsights.com
Linkedin | Twitter | BLogs

This release was published on openPR.